Cognitive Predictors of Donepezil Therapy Response in Alzheimer Disease

Publisher： Karger

E-ISSN： 1421-9824|24|1|28-35

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.24, Iss.1, 2007-05, pp. : 28-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 295-300

Karger

Access to resources Recommend Favorite

Effect of ApoE Genotype on Response to Donepezil in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 445-450

Karger

Access to resources Recommend Favorite

Cholinergic Deficit and Response to Donepezil Therapy in Parkinson’s Disease with Dementia

By  

European Neurology, Vol. 68, Iss. 3, 2012-07 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 353-363

Karger

Access to resources Recommend Favorite

SPECT-Identified Neuroanatomical Predictor of the Cognitive Effects of Donepezil Treatment in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 6, 2008-12 ,pp. : 556-566

Karger

Access to resources Recommend Favorite